The "Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering
DUBLIN--(BUSINESS WIRE)--Nov 2, 2022--
Asia Pacific single cell multiomics market will grow by 21.8% annually with a total addressable market cap of $ 16,032.0 million over 2022-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter's Five Forces
Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Instruments
Consumables
Software
Based on Omics Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Single Cell Genomics (SCG)
Single Cell Transcriptomics (SCT)
Single Cell Proteomics (SCP)
Single Cell Metabolomics (SCM)
By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Clinical Research
Oncology
Cell Therapy
Immunology
Neurology
Cell Biology
Other Types of Clinical Research
Translation Research
Synthetic Biology
By Sample Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Human Samples
Cancer Tissues
Stem Cells
Immune Cells
Brain Cells
Other Human Samples
Animal Samples
Microbial Samples
By Workflow, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Single-Cell Isolation and Dispensing
Fluorescence-Activated Cell Sorting (FACS)
Microfluidics
Magnetic-Activated Cell Sorting (MACS)
Random Seeding
Manual Cell Picking
Laser Capture Microdissection
Other Technologies of Single-Cell Isolation and Dispensing
Single-Cell Analysis
Polymerase Chain Reaction
Next-Generation Sequencing
Mass Cytometry
Mass Spectrometry
Other Technologies of Single-Cell Analysis
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Research and Academic Laboratories
Biopharmaceutical and Biotech Companies
Contract Research Organizations (CROs)
Other End Users
Geographically, the following national/local markets are fully investigated:
Japan
China
South Korea
Australia
India
Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
10x Genomics, Inc.
1CellBio, Inc.
Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc.
2 Market Overview and Dynamics
3 Segmentation of Asia Pacific Market by Product Type
4 Segmentation of Asia Pacific Market by Omics Type
5 Segmentation of Asia Pacific Market by Application
6 Segmentation of Asia Pacific Market by Sample Type
7 Segmentation of Asia Pacific Market by Workflow
8 Segmentation of Asia Pacific Market by End User
9 Asia-Pacific Market 2021-2031 by Country
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/02/2022 01:22 PM/DISC: 11/02/2022 01:22 PM
http://www.businesswire.com/news/home/20221102005875/en